Canadian medical device company ABK Biomedical, Inc. has landed $30 million in Series B funding round.

F-Prime Capital and Varian Medical Systems co-led the funding round.

ABK Biomedical is planning to use the funds to support the research and development, manufacturing, and the clinical development program designed for regulatory submission of both Eye90 and Easi-Vue.

The company has raised a total of $37.4 million in over three funding rounds.